STATERA BIOPHARMA INC by Statera Biopharma, Inc. (STAB) Stock Price, Quote, News & History

STABOTCEM

Trade with Public

$0.0911

-0.005-5.20%

At close: Jan 10, 4:00 PM EST

$0.00010

-0.096-99.90%

Pre-Market: Jul 18, 5:00 PM EST

OverviewNews Earnings Short Interest

Key Statistics

Open

$0.09

Volume / Avg.

0 / 7.80K

Day Range

- - -

52 Wk Range

0.00 - 0.03

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

13.32

Recent Statera Biopharma Inc News

Statera Biopharma Shares Fall After Taking Stake In Holographic Medical Imaging

Vandana Singh

The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.09M

Investing Cash Flow (TTM)

-103.37K

Financing Cash Flow (TTM)

-1.60M

Free Cash Flow (TTM)

-12.19M

Capital Expenditure (TTM)

-103.37K

Net Change in Cash (TTM)

-13.79M

Valuation Metrics

Enterprise Value

$7.14K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$6.40M

LT Debt

LT Debt Issuance (TTM)

$500.00K

LT Debt Repayment (TTM)

-$10.10M

Total Cash

$506.10K

Debt to Equity

Issuance of Debt (TTM)

-$9.60M

Repayment of Debt (TTM)

-$10.10M

Key Statistics

Open

$0.09

Volume / Avg.

0 / 7.80K

Day Range

- - -

52 Wk Range

0.00 - 0.03

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

13.32

About

Sector

Health Care

Industry

Biotechnology

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like recept...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy STATERA BIOPHARMA INC by Statera Biopharma, Inc. (STAB) stock?

You can purchase shares of STATERA BIOPHARMA INC by Statera Biopharma, Inc. (OTCEM:STAB) through any online brokerage.

View our list of the best stock brokerages

Who are STATERA BIOPHARMA INC by Statera Biopharma, Inc. (STAB) competitors?

There are no as such competitors for STATERA BIOPHARMA INC by Statera Biopharma, Inc..

What is the forecast, or price target, for STATERA BIOPHARMA INC by Statera Biopharma, Inc. (STAB) stock?

There is no analysis for STATERA BIOPHARMA INC by Statera Biopharma, Inc. to provide a consensus price target.

What is the current price for STATERA BIOPHARMA INC by Statera Biopharma, Inc. (STAB)?

The stock price for STATERA BIOPHARMA INC by Statera Biopharma, Inc. (OTCEM: STAB) is $0.0001 last updated June 11, 2026 at 12:08 PM EDT.

Does STATERA BIOPHARMA INC by Statera Biopharma, Inc. (STAB) pay a dividend?

There are no upcoming dividends for STATERA BIOPHARMA INC by Statera Biopharma, Inc..

When is STATERA BIOPHARMA INC by Statera Biopharma, Inc. (OTCEM:STAB) reporting earnings?

STATERA BIOPHARMA INC by Statera Biopharma, Inc. does not have any upcoming earnings scheduled.

Is STATERA BIOPHARMA INC by Statera Biopharma, Inc. (STAB) going to split?

There is no upcoming split for STATERA BIOPHARMA INC by Statera Biopharma, Inc..

What sector and industry does STATERA BIOPHARMA INC by Statera Biopharma, Inc. (STAB) operate in?

STATERA BIOPHARMA INC by Statera Biopharma, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.